Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)

Clinical trial NCT03415854 · COMPLETED

Trial details

NCT number: NCT03415854
Sponsor: HonorHealth Research Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer Pancreatic Ductal Adenocarcinoma Pancreatic Adenocarcinoma Pancreas Metastases Adenocarcinoma

Start date: 2018-01-31
Primary completion: 2023-12-11
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.